Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Novaliq

    Client Virtual Booth

    NOVALIQ

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Novaliq
    Germany Flag
    Country
    Country
    Germany
    Address
    Address
    Im Neuenheimer Feld 515 69120 Heidelberg
    Telephone
    Telephone
    +49 6221 50259-0
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.novaliq.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/novaliq/
    Twitter
    Twitter
    https://twitter.com/novaliq

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    EMA Accepts Novaliq’s MAA for CyclASol for the Treatment of Dry Eye Disease
    EMA Accepts Novaliq’s MAA for CyclASol for the Treatment of Dry Eye Disease

    https://www.businesswire.com/news/home/20230824122107/en

    BUSINESSWIRE
    24 Aug 2023
    Share Share
    Harrow Acquires U.S. and Canadian Commercial Rights to VEVYE from Novaliq
    Harrow Acquires U.S. and Canadian Commercial Rights to VEVYE from Novaliq

    https://www.businesswire.com/news/home/20230718821365/en

    BUSINESSWIRE
    18 Jul 2023
    Share Share
    Senju Pharmaceutical and Novaliq Enter Into License Agreement For NOV03
    Senju Pharmaceutical and Novaliq Enter Into License Agreement For NOV03

    https://www.businesswire.com/news/home/20230612304814/en

    BUSINESSWIRE
    13 Jun 2023
    Share Share
    Novaliq Announces FDA Approval of VEVYE 0.1% for Treatment of Dry Eye Disease
    Novaliq Announces FDA Approval of VEVYE 0.1% for Treatment of Dry Eye Disease

    https://www.businesswire.com/news/home/20230608005090/en

    BUSINESSWIRE
    08 Jun 2023
    Share Share
    Bausch + Lomb and Novaliq win approval for dry eye disease treatment
    Bausch + Lomb and Novaliq win approval for dry eye disease treatment

    https://endpts.com/bausch-lomb-and-novaliq-win-approval-for-dry-eye-disease-treatment/

    Nicole DeFeudis ENDPTS
    19 May 2023
    Share Share
    Novaliq Announces Presentation of New Scientific Data on Cyclosporine
    Novaliq Announces Presentation of New Scientific Data on Cyclosporine

    https://www.businesswire.com/news/home/20230502005113/en

    BUSINESSWIRE
    02 May 2023
    Share Share
    Novaliq Announces Publication of Second Pivotal PIII Trial Data on CyclASol 0.1%
    Novaliq Announces Publication of Second Pivotal PIII Trial Data on CyclASol 0.1%

    https://www.businesswire.com/news/home/20230412005078/en

    BUSINESSWIRE
    12 Apr 2023
    Share Share
    Novaliq Plans to File Markting Authorisation Application for CyclASol in E.U.
    Novaliq Plans to File Markting Authorisation Application for CyclASol in E.U.

    https://www.businesswire.com/news/home/20230208005056/en

    BUSINESSWIRE
    08 Feb 2023
    Share Share
    Bausch + Lomb and Novaliq Announce Publication of Pivotal Phase 3 Data on NOV03
    Bausch + Lomb and Novaliq Announce Publication of Pivotal Phase 3 Data on NOV03

    https://www.businesswire.com/news/home/20230104005244/en

    BUSINESSWIRE
    04 Jan 2023
    Share Share
    Novaliq Announces FDA Acceptance of the New Drug Application for CyclASol
    Novaliq Announces FDA Acceptance of the New Drug Application for CyclASol

    https://www.businesswire.com/news/home/20221024005092/en

    BUSINESSWIRE
    24 Oct 2022
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search